CorDx Presents Innovative 3-in-1 Diagnostic Solution at APCMV 2024 in Singapore

From November 19-21, CorDx had the pleasure of participating in APCMV 2024, one of Asia's premier events for medical diagnostics. CorDx used this platform to showcase the CorDx Tyfast Flu A/B & COVID-19 Multiplex Rapid Test, a groundbreaking diagnostic tool designed to detect influenza A, influenza B, and SARS-CoV-2 antigens with precision.

The CorDx Tyfast Flu A/B & COVID-19 test provides accurate results in just 10 minutes, allowing users to make informed health decisions quickly and confidently. This 3-in-1 rapid test combines convenience and accuracy, offering a highly efficient solution for early detection of common respiratory viruses. APCMV attendees were able to explore the features and benefits of this diagnostic tool and see firsthand how CorDx’s innovation addresses the need for rapid, reliable results in home healthcare.

CorDx appreciated the opportunity to connect with industry professionals at APCMV 2024 and looks forward to continuing our mission of empowering individuals with convenient and dependable diagnostics. Thank you to everyone who visited our booth and engaged with our team – we look forward to seeing you at future events!